Company Analysis
Sign in

Filana Therapeutics, Inc. (FLNA)

Nasdaq: FLNA · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2000
Full chart Alerts Compare
Grade5.5
◀ Past 5.0● Present 4.0▶ Future 7.2
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

24 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Filana Therapeutics, Inc.’s names, not what it holds today.

Patents granted
24
24 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 1 in 2023
Applications published
26
3 of them in 2025
Names they are printed under
4
a former name
By yearGrantedApplications published
'06'09'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry4
Pharmaceuticals2
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Pain Therapeutics, Inc. a former name
US, as the owner printed on each patent
18 granted
10 published
Cassava Sciences, Inc. a former name
US, as the owner printed on each patent
6 granted
7 published
Pain Therapeutics, Inc. a former name
named as the applicant on its applications, in US
0 granted
7 published
Cassava Sciences, Inc. a former name
named as the applicant on its applications, in US
0 granted
2 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 19, 202512,391,693Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsOrganic fine chemistryCassava Sciences, Inc.
Aug 20, 202412,065,440Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsOrganic fine chemistryCassava Sciences, Inc.
May 30, 202311,661,580Method of inhibiting tau phosphorylationOrganic fine chemistryCassava Sciences, Inc.
Jul 12, 202211,385,221Alzheimer's disease assay in a living patientAnalysis of biological materialsPain Therapeutics, Inc.
Jun 28, 202211,370,791Solid polymorphs of a FLNA-binding compound and its hydrochloride saltsOrganic fine chemistryCassava Sciences, Inc.
Aug 24, 202111,096,936Cocrystals of naloxone and naltrexonePharmaceuticalsCassava Sciences, Inc.
Apr 20, 202110,980,799Crystalline salts of naloxone and naltrexonePharmaceuticalsPain Therapeutics, Inc.
Sep 1, 202010,760,052Method of inhibiting tau phosphorylationOrganic fine chemistryCassava Sciences, Inc.
Jul 30, 201910,363,239Method for inhibiting growth of cancer cellsPharmaceuticalsPain Therapeutics, Inc.
Mar 5, 201910,222,368Alzheimer's disease assay in a living patientAnalysis of biological materialsPain Therapeutics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 22, 20252025/0163372METHOD OF INHIBITING TAU PHOSPHORYLATIONOrganic fine chemistryCassava Sciences, Inc.
Mar 20, 20252025/0092361METHOD OF INHIBITING TAU PHOSPHORYLATIONOrganic fine chemistryCassava Sciences, Inc.
Mar 13, 20252025/0084083SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTSOrganic fine chemistryCassava Sciences, Inc. · patent 12,391,693 granted from it
Dec 5, 20242024/0400566SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTSOrganic fine chemistryCassava Sciences, Inc.
Oct 3, 20242024/0329056COMPONENT ASSAY FOR ALZHEIMER'S DISEASE IN A LIVING SUBJECTAnalysis of biological materialsCassava Sciences, Inc.
Apr 11, 20242024/0117306METHOD OF INHIBITING TAU PHOSPHORYLATIONOrganic fine chemistryCassava Sciences, Inc.
May 11, 20232023/0144446BLOOD-BASED DIAGNOSTIC ASSAYS FOR ALZHEIMER'S DISEASEAnalysis of biological materialsCassava Sciences, Inc.
Oct 27, 20222022/0340574SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTSOrganic fine chemistryCassava Sciences, Inc. · patent 12,065,440 granted from it
Jul 28, 20222022/0233512INHIBITING AN IMMUNE RESPONSE MEDIATED BY ONE OR MORE OF TLR2, RAGE, CCR5, CXCR4 AND CD4PharmaceuticalsCassava Sciences, Inc.
Dec 16, 20212021/0389298Alzheimer's Disease Assay in a Living PatientOrganic fine chemistryPain Therapeutics, Inc.
What it applied for, 2024 to 2025: Organic fine chemistry 5 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton FLNA · research, not advice